MK615 is produced from Japanese apricot and contains several cyclic triterpenes, such as oleanolic and ursolic acids. MK615 was shown to strongly suppress cutaneous in-transit metastasis in a patient with malignant melanoma. The present investigation was undertaken to clarify the antitumor effects of MK615 in vitro and in vivo.
Methods
Several human cancer cell lines were exposed to MK615 for 7 days to examine its antiproliferative effects. The effect of MK615 on in vivo growth of human pancreatic cancer MIAPaCa-2 cells was also examined.
Results
MK615 inhibited the growth of several human cancer cell lines in a concentration-dependent way. Pancreatic cancer MIAPaCa-2 cells were highly sensitive to the growth-inhibiting effects of MK615. Treatment with MK615 preferentially induced cell death in human cancer cells while sparing normal cells such as human umbilical vein endothelial cells (HUVEC) and mouse bone marrow cells. When MIAPaCa-2 cells were incubated with MK615 in the presence of antioxidant, growth-inhibition was significantly reduced, and MK615 induced the accumulation of reactive oxygen species in cancer cells but not in HUVEC. MK615, in both the presence and absence of gemcitabine, significantly inhibited the growth of human pancreatic cancer cells as xenografts without apparent adverse effects.
Conclusions
MK615, a supplement produced from Japanese apricot, may have therapeutic value in treating human cancers through a reactive oxygen species-dependent mechanism.
HansonJ.R.: The development of strategies for torpedoed structure determination.Nat Prod Rep, 18: 607–617, 2001.
2.
AdachiM., SuzukiY., MizutaT., OsawaT., AdachiT., OsawaK., SuzukiK., ShojimaK., AraiY., MasudaK., UchiyamaM., OyamadaT., ClericiM.: The Japanese apricot Prunus mume Sieb. et Zucc (ume) is a rich natural source of novel anticancer substance.Int J Food Prop, 10: 375–384, 2007.
3.
GuttermanJ.U., LaH.T., YangP., HaridasV., GaikwadA., MarcusS.: Effects of the tumor inhibitory triterpenoid avicin G on cell integrity, cytokinesis, and protein ubiquitination in fission yeast.Proc Natl Acad Sci USA, 102: 12771–12776, 2005.
4.
RamachandranC., RabiT., FonsecaH.B., MelnikS.J., EscalonE.A.: Novel plant triterpenoid drug amooranin overcomes multidrug resistance in human leukemia and colon carcinoma cell lines.Int J Cancer, 105: 784–789, 2003.
5.
NakagawaA., SawadaT., OkadaT., OhsawaT., AdachiM., KubotaK.: New antineoplastic agent MK615, from Ume (a variety of) Japanese apricot inhibits growth of breast cancer cells in vitro.Breast J, 13: 44–49, 2007.
6.
OkadaT., SawadaT., OsawaT., AdachiM., KubotaK.: A novel anti-cancer substance, MK615, from ume, a variety of Japanese apricot, inhibits growth of hepatocellular carcinoma cells by suppressing Aurora A kinase activity.Hepatogastroenterology, 54: 1770–1774, 2007.
7.
MoriS., SawadaT., OkadaT., OhsawaT., AdachiM., KubotaK.: New anti-proliferative agent, MK615, from Japanese apricot “Prunus mume” induces striking autophagy in colon cancer cells in vitro.World J Gastroenterol, 28: 6512–6517, 2007.
8.
MorimotoY., KikuchiK., ItoT., MatsuyamaT., NomaS., HashiguchiT., ToriiM., MaruyamaI., KawaharaK.: MK615 attenuates Porphyromonas gingivalis lipopolysaccharide-induced proinflammatory cytokine release via MAPK inactivation in murine macrophage-like RAW 264.7 cells.Biochem Biophys Res Commun, 389: 90–94, 2009.
9.
YamaiH., SawadaN., YoshidaT., SeikeJ., TakizawaH., KenzakiK., MiyoshiT., KondoK., BandoY., OhnishiY., TangokuA.: Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo.Int J Cancer, 125: 952–960, 2009.
10.
MatsushitaS., TadaK., KawaharaK., KawaiK., HashiguchiT., MaruyamaI., KanekuraT.: Advanced malignant melanoma responds to Prunus mume Sieb. Et Zucc (Ume) extract: case report and in vitro study.Exp Ther Med, 1: 569–574, 2010.
11.
IraniK., XiaY., ZweierJ.L., SollottS.J., DerC.J., FearonE.R., SundaresanM., FinkelT., Goldschmidt-ClermontP.: Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts.Science, 275: 1649–1652, 1997.
12.
SattlerM., VermaS., ShrikhandeG., BymeC.H., PrideY.B., WinklerT., GreenfieldE.A., SalgiaR., GriffinJ.D.: The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells.J Biol Chem, 275: 24273–24278, 2000.
13.
VafaO., WadeM., KernS., BeecheM., PanditaT.K., HamptonG.M., WahlG.M.: c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability.Mol Cell, 9: 1031–1044, 2002.
14.
SzatrowskiT.P., NathanC.F.: Production of large amounts of hydrogen peroxide by human tumor cells.Cancer Res, 51: 794–798, 1977.
15.
PelicanoH., CarneyD., HuangP.: ROS stress in cancer cells and therapeutic implications.Drug Resist Update, 7: 97–110, 2004.
16.
AlexandreJ., HuY., LuY., LuW., PelicanoH., HuangP.: Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species.Cancer Res, 67: 3512–3517, 2007.
17.
KhanN., AfaqF., SaleemM., AhmadN., MukhtarH.: Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.Cancer Res, 66: 2500–2505, 2006.
18.
SarkarF.H., LiY.: Using chemopreventive agents to enhance the efficacy of cancer therapy.Cancer Res, 66: 3347–3350, 2006.
19.
NgoS.N., WilliamsD.B., HeadR.J.: Rosemary and cancer prevention: preclinical perspectives.Crit Rev Food Sci Nutr, 51: 946–954, 2011.
20.
FosterR., MetcalfD., KirchmyerR.: Induction of bone marrow colony-stimulating activity by a filterable agent in leukemic and normal mouse serum.J Exp Med, 127: 853–866, 1968.
21.
GotoI., Yamamoto-YamaguchiY., HonmaY.: Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon-α by differentiation-inducing agents.Br J Cancer, 74: 546–554, 1996.
22.
HonmaY., Yamamoto-YamaguchiY., KanataniY.: Vesnari-none and glucocorticoids cooperatively induce G1 arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice.Br J Cancer, 80: 96–103, 1999.
23.
IshiiY., HoriY., SakaiS., HonmaY.: Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin nucleosides, plant redifferentiation-inducing hormones.Cell Growth Diff, 13: 19–26, 2002.
24.
ChouT.C., TalalayP.: Quantitative analysis of dose-effect relationship: the combined effects of multiple drugs or enzyme inhibitors.Adv Enzyme Regul, 22: 27–55, 1984.
25.
KawakamiK., HattoriM., InoueT., MaruyamaY., OhkandaJ., KatoN., TonguM., YamadaT., AkimotoM., TakenagaK., SassaT., SuzumiyaJ., HonmaY.: A novel fusicoccin derivative preferentially targets hypoxic tumor cells and inhibits tumor growth in xenografts.Anticancer Agents Med Chem, 12: 791–800, 2012.
26.
StrimpakosA.S., SyrigosK.N., SaifM.W.: The molecular targets for the diagnosis and treatment of pancreatic cancer.Gut Liver, 4: 433–449, 2010.
27.
RajL., IdeT., GurkarA.U., FoleyM., SchenoneM., LiX., TollidayN.J., GolubT.R., CarrsA., ShamiA.F., StemA.M., MandinovaA.: Selective killing of cancer cells by a small molecule targeting the stress response to ROS.Nature, 475: 231–234, 2011.
28.
SchumackerP.T.: Reactive oxygen species in cancer cells: live by the sword, die by the sword.Cancer Cell, 10: 175–176, 2006.
29.
TrachoothamD., ZhouY., ZhangH., DemizuY., ChenZ., PelicanoH., ChiaoP.J., AchantaG., ArlinghausR.B., LiuJ., HuangP.: Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylehtyl isocyanate.Cancer Cell, 10: 241–252, 2006.
30.
RavindranJ., PrasadS., AggarwalB.B.: Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?Am Assoc Pharm Sci J, 11: 495–510, 2009.
31.
YueP., ZhouZ., KhuriF.R., SunS.Y.: Depletion of intracellular glutatnione contributes to JNK-mediated death receptor 5 upregulation and apoptosis induction by novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate (CDDO-Me).Cancer Biol Ther, 5: 492–497, 2006.
32.
MorganM.J., LiuZ.G.: Reactive oxygen species in TNFalpha-induced signaling and cell death.Mol Cells, 30: 1–12, 2010.
33.
DhanasekaranD.N., ReddyE.P.: JNK signaling in apoptosis.Oncogene, 27: 6245–6251, 2008.
34.
FengY., WangN., ZhuM., FengY., LiH., TsaoS.: Recent progress on anticancer candidates in patents of herbal medicinal products.Recent Pat Food Nutr Agric, 3: 30–48, 2011.
